Search Results - "Park, Yara"

How do I reduce variation in red blood cell transfusion practices in a large integrated health care system? by Entzel, Pamela, Nielsen, Matthew, Weiss, Susan, Park, Yara A., Lu, Rommel, Baskin‐Miller, Jacquelyn, Hutchinson, Blake, Obioma, Prestige, An, Xinming, Balfanz, Greg

“…Background Reducing variation in transfusion practices can prevent unwarranted transfusions, an outcome that improves quality of care and patient safety, while…”
Get full text

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients by Premkumar, Lakshmanane, Segovia-Chumbez, Bruno, Jadi, Ramesh, Martinez, David R, Raut, Rajendra, Markmann, Alena, Cornaby, Caleb, Bartelt, Luther, Weiss, Susan, Park, Yara, Edwards, Caitlin E, Weimer, Eric, Scherer, Erin M, Rouphael, Nadine, Edupuganti, Srilatha, Weiskopf, Daniela, Tse, Longping V, Hou, Yixuan J, Margolis, David, Sette, Alessandro, Collins, Matthew H, Schmitz, John, Baric, Ralph S, de Silva, Aravinda M

“…The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that first emerged in late 2019 is responsible for a pandemic of severe respiratory illness…”
Get more information

Effects of Red-Cell Storage Duration on Patients Undergoing Cardiac Surgery by Steiner, Marie E, Ness, Paul M, Assmann, Susan F, Triulzi, Darrell J, Sloan, Steven R, Delaney, Meghan, Granger, Suzanne, Bennett-Guerrero, Elliott, Blajchman, Morris A, Scavo, Vincent, Carson, Jeffrey L, Levy, Jerrold H, Whitman, Glenn, D’Andrea, Pamela, Pulkrabek, Shelley, Ortel, Thomas L, Bornikova, Larissa, Raife, Thomas, Puca, Kathleen E, Kaufman, Richard M, Nuttall, Gregory A, Young, Pampee P, Youssef, Samuel, Engelman, Richard, Greilich, Philip E, Miles, Ronald, Josephson, Cassandra D, Bracey, Arthur, Cooke, Rhonda, McCullough, Jeffrey, Hunsaker, Robert, Uhl, Lynne, McFarland, Janice G, Park, Yara, Cushing, Melissa M, Klodell, Charles T, Karanam, Ravindra, Roberts, Pamela R, Dyke, Cornelius, Hod, Eldad A, Stowell, Christopher P

“…In a trial involving nearly 1100 patients undergoing cardiac surgery, there were no significant differences in outcomes among patients receiving transfusions…”
Get full text

Evaluation of a COVID-19 convalescent plasma program at a U.S. academic medical center by Root, Heather B, Gilleskie, Matt, Lu, Chih-Huan, Gilmore, Andrew, Evans, Mariama, Nelson, Bridget G, Johnson, William, Gurney, Brian, Kuruc, JoAnn, Markmann, Alena J, Barzin, Amir H, Wohl, David A, Fischer, William A, Park, Yara A, Weiss, Susan, Napravnik, Sonia, Baric, Ralph, de Silva, Aravinda M, Lachiewicz, Anne M, van Duin, David, Margolis, David M, Herce, Michael E, Bartelt, Luther A

“…Amidst the therapeutic void at the onset of the COVID-19 pandemic, a critical mass of scientific and clinical interest coalesced around COVID-19 convalescent…”
Get full text

Antibody Titers in Transfusion Medicine by Karafin, Matthew S, DeSimone, Robert A, Dvorak, James, Metcalf, Ryan A, Pagano, Monica B, Park, Yara A, Schwartz, Joseph, Souers, Rhona J, Szczepiorkowski, Zbigniew M, Uhl, Lynne, Ramsey, Glenn

“…Because of the fact that the testing conditions are known to differ over time, many laboratories still require that previously tested samples be retested…”
Get full text

Blood conservation strategies at United States hospitals during the COVID‐19 pandemic: Findings from a multi‐institutional analysis ‐ International Society of Blood Transfusion survey by Jacobs, Jeremy W., Karafin, Matthew S., Allen, Elizabeth S., Abels, Elizabeth, Park, Yara A., Stephens, Laura D., Ward, Dawn C., Woo, Jennifer S., Gehrie, Eric A., Booth, Garrett S., Adkins, Brian D.

“…Background Due to the coronavirus disease 2019 (COVID‐19) pandemic, the transfusion medicine community has experienced unprecedented blood supply shortages…”
Get full text

Antibody Titers in Transfusion Medicine: A Critical Reevaluation of Testing Accuracy, Reliability, and Clinical Use by Karafin, Matthew S, DeSimone, Robert A, Dvorak, James, Metcalf, Ryan A, Pagano, Monica B, Park, Yara A, Schwartz, Joseph, Souers, Rhona J, Szczepiorkowski, Zbigniew M, Uhl, Lynne, Ramsey, Glenn

“…Substantial variability between different antibody titration methods has been identified since the development and introduction of the uniform procedure in…”
Get full text

ASFA's Response to 'Gender Inequities in Transfusion Medicine Society Recognition Awards' by Doggett, Betty, Aqui, Nicole A, Miller, Yvette M, Park, Yara A., Schneiderman, Jennifer, Linenberger, Michael

Get full text

Race, rituximab, and relapse in TTP by Chaturvedi, Shruti, Antun, Ana G, Farland, Andrew M, Woods, Ryan, Metjian, Ara, Park, Yara A, de Ridder, Gustaaf, Gibson, Briana, Kasthuri, Raj S, Liles, Darla K, Akwaa, Frank, Clover, Todd, Baumann Kreuziger, Lisa, Sadler, J Evan, Sridharan, Meera, Go, Ronald S, McCrae, Keith R, Upreti, Harsh Vardhan, Liu, Angela, Lim, Ming Y, Gangaraju, Radhika, Zheng, X Long, Raval, Jay S, Masias, Camila, Cataland, Spero R, Johnson, Andrew, Davis, Elizabeth, Evans, Michael D, Mazepa, Marshall A

“…Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is characterized by recurring episodes of thrombotic microangiopathy, causing ischemic organ…”
Get full text

Obstetric and Newborn Weak D-Phenotype RBC Testing and Rh Immune Globulin Management Recommendations: Lessons From a Blinded Specimen-Testing Survey of 81 Transfusion Services by Ramsey, Glenn, Park, Yara A, Eder, Anne F, Bobr, Aleh, Karafin, Matthew S, Karp, Julie K, King, Karen E, Pagano, Monica B, Schwartz, Joseph, Szczepiorkowski, Zbigniew M, Souers, Rhona J, Thomas, Lamont, Delaney, Meghan

“…Modern RHD genotyping can be used to determine when patients with serologic weak D phenotypes have RHD gene variants at risk for anti-D alloimmunization…”
Get full text

Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors by Vincent, Benjamin G, File, Danielle M, McKinnon, Karen P, Moore, Dominic T, Frelinger, Jeffrey A, Collins, Edward J, Ibrahim, Joseph G, Bixby, Lisa, Reisdorf, Shannon, Laurie, Sonia J, Park, Yara A, Anders, Carey K, Collichio, Frances A, Muss, Hyman B, Carey, Lisa A, van Deventer, Hendrik W, Dees, E Claire, Serody, Jonathan S

“…Previous work from our group and others has shown that patients with breast cancer can generate a T cell response against specific human epidermal growth…”
Get full text

Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura by Mazepa, Marshall A., Raval, Jay S., Moll, Stephan, Ma, Alice, Park, Yara A.

Get full text

Therapeutic plasma exchange taper does not decrease exacerbations in immune thrombotic thrombocytopenic purpura patients by Raval, Jay S., Mazepa, Marshall A., Rollins‐Raval, Marian A., Kasthuri, Raj S., Park, Yara A.

“…BACKGROUND Despite rapid and intensive treatments with therapeutic plasma exchange (TPE) and immunosuppression, immune thrombotic thrombocytopenic purpura…”
Get full text

Taking Empiricism out of Immune Thrombotic Thrombocytopenic Purpura: Current and Future Treatment Strategies by Mazepa, Marshall A, Park, Yara A, Raval, Jay S

“…Immune thrombotic thrombocytopenic purpura (iTTP) is a chronically relapsing, humorally-mediated autoimmune disorder characterized by unpredictable episodes of…”
Get full text

Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study by Beigel, John H, Dr, Tebas, Pablo, MD, Elie-Turenne, Marie-Carmelle, MD, Bajwa, Ednan, MD, Bell, Todd E, MD, Cairns, Charles B, MD, Shoham, Shmuel, MD, Deville, Jaime G, MD, Feucht, Eric, MD, Feinberg, Judith, MD, Luke, Thomas, MD, Raviprakash, Kanakatte, PhD, Danko, Janine, MD, O'Neil, Dorothy, MS, Metcalf, Julia A, MT, King, Karen, MD, Burgess, Timothy H, MD, Aga, Evgenia, MSc, Lane, H Clifford, MD, Hughes, Michael D, PhD, Davey, Richard T, MD

“…Summary Background Influenza causes substantial morbidity and mortality despite available treatments. Anecdotal reports suggest that plasma with high antibody…”
Get full text

Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease by Desai, Payal C., Deal, Allison M., Pfaff, Emily R., Qaqish, Bahjat, Hebden, Leyna M., Park, Yara A., Ataga, Kenneth I.

“…Red blood cell (RBC) alloimmunization is a significant clinical complication of sickle cell disease (SCD). It can lead to difficulty with cross‐matching for…”
Get full text

Use of Fetal Hemoglobin Quantitation for Rh-Positive Pregnant Females: A National Survey and Review of the Literature by Karafin, Matthew S, Glisch, Chad, Souers, Rhona J, Hudgins, Jay, Park, Yara A, Ramsey, Glenn E, Lockhart, Evelyn, Pagano, Monica B

“…The Kleihauer-Betke (KB) test is validated for estimating the dose of Rh immune globulin needed for Rh-negative pregnant females. However, some clinicians are…”
Get full text

Reprioritising transfusion medicine education for graduating medical students by Peedin, Alexis R, Park, Yara A, Raval, Jay S

Get full text

A multi‐institutional survey of apheresis services among institutions in the United States by Yurtsever, Nalan, Jacobs, Jeremy W., Booth, Garrett S., Schwartz, Joseph, Park, Yara A., Woo, Jennifer S., Lauro, Deisen, Torres, Sarina, Ward, Dawn C., Stephens, Laura D., Allen, Elizabeth S., Tormey, Christopher A., Adkins, Brian D.

“…Introduction Apheresis practices in the United States (US) have not been comprehensively characterized to date. This study aimed to address this gap by…”
Get full text

Considerations for immune effector cell therapy collections: a white paper from the American Society for Apheresis by Liu, Hien D., Su, Leon, Winters, Jeffrey L., Thibodeaux, Suzanne R., Park, Yara A., Wu, YanYun, Schwartz, Joseph, Zubair, Abba C., Schneiderman, Jennifer, Gupta, Gaurav K., Ramakrishnan, Sharanya, Aqui, Nicole A.

“…This white paper was developed to provide leukapheresis guidance for the collection of mononuclear cells from adult and pediatric patients who are destined for…”
Get full text